The Impact of Prenatal Short Messages (SMS) on Maternal and Newborn Health (SMS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02037087|
Recruitment Status : Completed
First Posted : January 15, 2014
Last Update Posted : April 7, 2016
|Condition or disease||Intervention/treatment||Phase|
|Short Message Service Text Messaging||Behavioral: Good household prenatal practice Behavioral: Care seeking Behavioral: Full bank of SMS||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||4467 participants|
|Intervention Model:||Factorial Assignment|
|Official Title:||The Impact of Prenatal Short Messages on Maternal and Newborn Health|
|Study Start Date :||September 2013|
|Actual Primary Completion Date :||October 2015|
|Actual Study Completion Date :||March 2016|
Experimental: Good household prenatal practice (GHPP)
The GHPP arm receives SMS messages regarding knowledge on nutrition, labor, non-medical pain management, breastfeeding, and depression. This arm also receives messages delivered to the control group.
Behavioral: Good household prenatal practice
Knowledge on nutrition, labor, non-medical pain management, breastfeeding and depression
Experimental: Care seeking (CS)
The CS arm receives SMS messages which include danger-sign recognition and reminders for government-subsidized projects. This arm also receives messages delivered to the control group.
Behavioral: Care seeking
Experimental: Full bank of SMS
This arm receives the SMS messages delivered to the GHPP, CS and control group.
Behavioral: Full bank of SMS
No Intervention: Control
Control group receives SMS messages regarding:
The three experimental groups receive the control messages as well.
- Newborn health [ Time Frame: the first month after birth ]Newborn health is measured by appropriateness of weight for gestational age.
- Neonatal Adverse Outcome Indicator (NAOI) [ Time Frame: the first month after birth ]The NAOI focuses on measuring severe neonatal morbidity.
- Actual number of prenatal visits over expected visits [ Time Frame: In the duration of pregnancy, an expected average of 9 months ]
- Uptake of government-subsidized programs [ Time Frame: In the duration of pregnancy, an expected average of 9 months, and 1 month after birth ]
This outcome is measured by the following metrics:
- Duration of folic acid
- Uptake of infant vaccinations
- C-section rate [ Time Frame: child birth ]
- Maternal health [ Time Frame: Child birth and 1 year after birth ]Maternal health is measured by change of perception in general health and postpartum depression.
- Near-miss [ Time Frame: In the duration of pregnancy, an expected average of 9 months, and childbirth ]The near-miss focuses on measuring severe maternal morbidity.
- Psychological outcomes [ Time Frame: In the duration of pregnancy, an expected average of 9 months ]Attitudes, personal norms, self-efficacy, social desirability, intentions, plans, susceptibility, expectations, and severity
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02037087
|Xi'an Jiaotong University|
|Xi'an, Shaanxi, China, 710049|
|Principal Investigator:||Yanfang Su, MA||Harvard School of Public Health|
|Principal Investigator:||Zhongliang Zhou, PhD||Health Science Center of Xi’an Jiaotong University|
|Principal Investigator:||Changzheng Yuan, MS||Harvard School of Public Health|
|Principal Investigator:||Jesse Heitner, MPP||Harvard School of Public Health|
|Principal Investigator:||Benjamin Campbell, BA||Dartmouth College|